Literature DB >> 6280073

Opiate receptor subclasses differ in their conformational requirements.

P W Schiller, J DiMaio.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6280073     DOI： 10.1038/297074a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Comparative conformational analysis of [D-Pen2,D-Pen5]enkephalin (DPDPE): a molecular mechanics study.

Authors:  B C Wilkes; P W Schiller
Journal:  J Comput Aided Mol Des       Date:  1991-08       Impact factor: 3.686

2.  A proposal for the molecular basis of mu and delta opiate receptor differentiation based on modeling of two types of cyclic enkephalins and a narcotic alkaloid.

Authors:  A Michel; G Villeneuve; J DiMaio
Journal:  J Comput Aided Mol Des       Date:  1991-12       Impact factor: 3.686

3.  Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study.

Authors:  P Gao
Journal:  J Comput Aided Mol Des       Date:  1996-08       Impact factor: 3.686

4.  [Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile.

Authors:  Longxiang Bai; Ziyuan Li; Jiajia Chen; Nga N Chung; Brian C Wilkes; Tingyou Li; Peter W Schiller
Journal:  Bioorg Med Chem       Date:  2014-02-19       Impact factor: 3.641

5.  Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.

Authors:  P W Schiller; T M Nguyen; G Weltrowska; B C Wilkes; B J Marsden; C Lemieux; N N Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Membrane-assisted molecular mechanism of neurokinin receptor subtype selection.

Authors:  R Schwyzer
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

Review 7.  Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain.

Authors:  Pegah Varamini; Istvan Toth
Journal:  Front Pharmacol       Date:  2013-12-13       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.